{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:18:59Z","timestamp":1790738339907,"version":"4.1.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T00:00:00Z","timestamp":1543968000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Hospices Civils de Lyon for \u2018Young Investigator\u2019"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,1]]},"DOI":"10.1093\/jac\/dky473","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T12:10:02Z","timestamp":1542197402000},"page":"625-632","source":"Crossref","is-referenced-by-count":41,"title":["Evaluation of the ability of linezolid and tedizolid to eradicate intraosteoblastic and biofilm-embedded <i>Staphylococcus aureus<\/i> in the bone and joint infection setting"],"prefix":"10.1093","volume":"74","author":[{"given":"L\u00e9lia","family":"Abad","sequence":"first","affiliation":[{"name":"CIRI \u2013 Centre International de Recherche en Infectiologie, Inserm, U1111, Universit\u00e9 Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Sup\u00e9rieure de Lyon, Universit\u00e9 Lyon, Lyon, France"},{"name":"Regional Reference Centre for Complex Bone and Joint Infection (CRIOAc Lyon), Hospices Civils de Lyon, Lyon, France"},{"name":"Universit\u00e9 Claude Bernard Lyon 1, Lyon, France"},{"name":"Department of Bacteriology, Institute for Infectious Agents, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Tafani","sequence":"additional","affiliation":[{"name":"CIRI \u2013 Centre International de Recherche en Infectiologie, Inserm, U1111, Universit\u00e9 Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Sup\u00e9rieure de Lyon, Universit\u00e9 Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Tasse","sequence":"additional","affiliation":[{"name":"CIRI \u2013 Centre International de Recherche en Infectiologie, Inserm, U1111, Universit\u00e9 Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Sup\u00e9rieure de Lyon, Universit\u00e9 Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Josse","sequence":"additional","affiliation":[{"name":"CIRI \u2013 Centre International de Recherche en Infectiologie, Inserm, U1111, Universit\u00e9 Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Sup\u00e9rieure de Lyon, Universit\u00e9 Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Chidiac","sequence":"additional","affiliation":[{"name":"CIRI \u2013 Centre International de Recherche en Infectiologie, Inserm, U1111, Universit\u00e9 Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Sup\u00e9rieure de Lyon, Universit\u00e9 Lyon, Lyon, France"},{"name":"Regional Reference Centre for Complex Bone and Joint Infection (CRIOAc Lyon), Hospices Civils de Lyon, Lyon, France"},{"name":"Universit\u00e9 Claude Bernard Lyon 1, Lyon, France"},{"name":"Department of Infectious Diseases, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Lustig","sequence":"additional","affiliation":[{"name":"Regional Reference Centre for Complex Bone and Joint Infection (CRIOAc Lyon), Hospices Civils de Lyon, Lyon, France"},{"name":"Universit\u00e9 Claude Bernard Lyon 1, Lyon, France"},{"name":"Department of Orthopaedic Surgery, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Ferry","sequence":"additional","affiliation":[{"name":"CIRI \u2013 Centre International de Recherche en Infectiologie, Inserm, U1111, Universit\u00e9 Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Sup\u00e9rieure de Lyon, Universit\u00e9 Lyon, Lyon, France"},{"name":"Regional Reference Centre for Complex Bone and Joint Infection (CRIOAc Lyon), Hospices Civils de Lyon, Lyon, France"},{"name":"Universit\u00e9 Claude Bernard Lyon 1, Lyon, France"},{"name":"Department of Infectious Diseases, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Diot","sequence":"additional","affiliation":[{"name":"CIRI \u2013 Centre International de Recherche en Infectiologie, Inserm, U1111, Universit\u00e9 Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Sup\u00e9rieure de Lyon, Universit\u00e9 Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Laurent","sequence":"additional","affiliation":[{"name":"CIRI \u2013 Centre International de Recherche en Infectiologie, Inserm, U1111, Universit\u00e9 Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Sup\u00e9rieure de Lyon, Universit\u00e9 Lyon, Lyon, France"},{"name":"Regional Reference Centre for Complex Bone and Joint Infection (CRIOAc Lyon), Hospices Civils de Lyon, Lyon, France"},{"name":"Universit\u00e9 Claude Bernard Lyon 1, Lyon, France"},{"name":"Department of Bacteriology, Institute for Infectious Agents, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Valour","sequence":"additional","affiliation":[{"name":"CIRI \u2013 Centre International de Recherche en Infectiologie, Inserm, U1111, Universit\u00e9 Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Sup\u00e9rieure de Lyon, Universit\u00e9 Lyon, Lyon, France"},{"name":"Regional Reference Centre for Complex Bone and Joint Infection (CRIOAc Lyon), Hospices Civils de Lyon, Lyon, France"},{"name":"Universit\u00e9 Claude Bernard Lyon 1, Lyon, France"},{"name":"Department of Infectious Diseases, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,12,4]]},"reference":[{"key":"key\n\t\t\t\t2019021507302860100_dky473-B1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0140-6736(04)16727-5","article-title":"Osteomyelitis","volume":"364","author":"Lew","year":"2004","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0140-6736(14)61798-0","article-title":"Periprosthetic joint infection","volume":"387","author":"Kapadia","year":"2016","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s11908-005-0043-8","article-title":"Virulence determinants in Staphylococcus aureus and their involvement in clinical syndromes","volume":"7","author":"Ferry","year":"2005","journal-title":"Curr Infect Dis Rep"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/apm.12687","article-title":"Orthopaedic biofilm infections","volume":"125","author":"Zimmerli","year":"2017","journal-title":"APMIS"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cis803","article-title":"Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America","volume":"56","author":"Osmon","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B6","doi-asserted-by":"crossref","first-page":"i37","DOI":"10.1093\/jac\/dku254","article-title":"Impact of bacterial biofilm on the treatment of prosthetic joint infections","volume":"69","author":"Jacqueline","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B7","doi-asserted-by":"crossref","first-page":"568.e1","DOI":"10.1016\/j.cmi.2015.01.026","article-title":"Delta-toxin production deficiency in Staphylococcus aureus: a diagnostic marker of bone and joint infection chronicity linked with osteoblast invasion and biofilm formation","volume":"21","author":"Valour","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fcimb.2015.00085","article-title":"Staphylococcus aureus vs. osteoblast: relationship and consequences in osteomyelitis","volume":"5","author":"Josse","year":"2015","journal-title":"Front Cell Infect Microbiol"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B9","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1128\/AAC.04359-14","article-title":"Antimicrobial activity against intraosteoblastic Staphylococcus aureus","volume":"59","author":"Valour","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B10","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1128\/AAC.02032-13","article-title":"Antimicrobial-related severe adverse events during treatment of bone and joint infection due to methicillin-susceptible Staphylococcus aureus","volume":"58","author":"Valour","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B11","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1469-0691.2005.01211.x","article-title":"The selection of resistance to and the mutagenicity of different fluoroquinolones in Staphylococcus aureus and Streptococcus pneumoniae","volume":"11","author":"Sierra","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B12","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/jac\/47.5.647","article-title":"Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus","volume":"47","author":"O\u2019Neill","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s40121-014-0032-z","article-title":"A retrospective review of the clinical experience of linezolid with or without rifampicin in prosthetic joint infections treated with debridement and implant retention","volume":"3","author":"Morata","year":"2014","journal-title":"Infect Dis Ther"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B14","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1128\/AAC.47.12.3964-3966.2003","article-title":"Linezolid penetration into bone and joint tissues infected with methicillin-resistant staphylococci","volume":"47","author":"Kutscha-Lissberg","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B15","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.1128\/AAC.00390-15","article-title":"In vitro activities of tedizolid and linezolid against Gram-positive cocci associated with acute bacterial skin and skin structure infections and pneumonia","volume":"59","author":"Chen","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B16","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.clinthera.2006.08.001","article-title":"Effectiveness and tolerability of prolonged linezolid treatment for chronic osteomyelitis: a retrospective study","volume":"28","author":"Senneville","year":"2006","journal-title":"Clin Ther"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B17","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1517\/14740330903049706","article-title":"Update on the safety of linezolid","volume":"8","author":"Metaxas","year":"2009","journal-title":"Expert Opin Drug Saf"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B18","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s40262-017-0601-x","article-title":"Clinical pharmacokinetics and pharmacodynamics of oxazolidinones","volume":"57","author":"Roger","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B19","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1128\/AAC.00663-10","article-title":"Structure-activity relationships of diverse oxazolidinones for linezolid-resistant Staphylococcus aureus strains possessing the cfr methyltransferase gene or ribosomal mutations","volume":"54","author":"Locke","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B20","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1099\/jmm.0.000595","article-title":"In vitro activity of tedizolid and comparator agents against Gram-positive pathogens responsible for bone and joint infections","volume":"66","author":"Ract","year":"2017","journal-title":"J Med Microbiol"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40121-015-0060-3","article-title":"Tedizolid phosphate: a next-generation oxazolidinone","volume":"4","author":"Rybak","year":"2015","journal-title":"Infect Dis Ther"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s40265-015-0352-7","article-title":"Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant Gram-positive pathogens","volume":"75","author":"Zhanel","year":"2015","journal-title":"Drugs"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/jac\/dkp002","article-title":"Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci","volume":"63","author":"Livermore","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B24","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/jama.2013.241","article-title":"Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial","volume":"309","author":"Prokocimer","year":"2013","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1128\/AAC.03684-14","article-title":"Nonclinical and pharmacokinetic assessments to evaluate the potential of tedizolid and linezolid to affect mitochondrial function","volume":"59","author":"Flanagan","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B26","first-page":"3743","article-title":"Characterization of osteosarcoma cell lines MG-63, Saos-2 and U-2 OS in comparison to human osteoblasts","volume":"24","author":"Pautke","year":"2004","journal-title":"Anticancer Res"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B27","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1124\/dmd.113.056697","article-title":"Absorption, distribution, metabolism, and excretion of the novel antibacterial prodrug tedizolid phosphate","volume":"42","author":"Ong","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B28","doi-asserted-by":"crossref","first-page":"ftw057","DOI":"10.1093\/femspd\/ftw057","article-title":"Preliminary results of a new antibiotic susceptibility test against biofilm installation in device-associated infections: the Antibiofilmogram\u00ae","volume":"74","author":"Tasse","year":"2016","journal-title":"Pathog Dis"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B29","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3747\/pdi.2010.00010","article-title":"MIC versus MBEC to determine the antibiotic sensitivity of Staphylococcus aureus in peritoneal dialysis peritonitis","volume":"30","author":"Girard","year":"2010","journal-title":"Perit Dial Int"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B30","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1099\/00221287-146-10-2395","article-title":"Quantification of biofilm structures by the novel computer program COMSTAT","volume":"146","author":"Heydorn","year":"2000","journal-title":"Microbiology"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/jor.20003","article-title":"Intracellular Staphylococcus aureus and antibiotic resistance: implications for treatment of staphylococcal osteomyelitis","volume":"24","author":"Ellington","year":"2006","journal-title":"J Orthop Res"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B32","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","article-title":"Bacterial biofilms: a common cause of persistent infections","volume":"284","author":"Costerton","year":"1999","journal-title":"Science"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B33","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/jac\/dks442","article-title":"Activity of ceftaroline against extracellular (broth) and intracellular (THP-1 monocytes) forms of methicillin-resistant Staphylococcus aureus: comparison with vancomycin, linezolid and daptomycin","volume":"68","author":"M\u00e9lard","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B34","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/jac\/dkt072","article-title":"Antibiotic activity against small-colony variants of Staphylococcus aureus: review of in vitro, animal and clinical data","volume":"68","author":"Garcia","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B35","doi-asserted-by":"crossref","first-page":"63.","DOI":"10.1186\/1741-7007-11-63","article-title":"Bacteria tracking by in vivo magnetic resonance imaging","volume":"11","author":"Hoerr","year":"2013","journal-title":"BMC Biol"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B36","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1093\/jac\/dkx314","article-title":"Intraosteoblastic activity of daptomycin in combination with oxacillin and ceftaroline against MSSA and MRSA","volume":"72","author":"Dupieux","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B37","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/jac\/dkl489","article-title":"Combined effect of pH and concentration on the activities of gentamicin and oxacillin against Staphylococcus aureus in pharmacodynamic models of extracellular and intracellular infections","volume":"59","author":"Baudoux","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B38","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1128\/AAC.01723-09","article-title":"Cellular pharmacokinetics of the novel biaryloxazolidinone radezolid in phagocytic cells: studies with macrophages and polymorphonuclear neutrophils","volume":"54","author":"Lemaire","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B39","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1128\/CMR.00120-16","article-title":"The role of antibiotics in modulating virulence in Staphylococcus aureus","volume":"30","author":"Hodille","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B40","doi-asserted-by":"crossref","first-page":"e63176","DOI":"10.1371\/journal.pone.0063176","article-title":"PSMs of hypervirulent Staphylococcus aureus act as intracellular toxins that kill infected osteoblasts","volume":"8","author":"Rasigade","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B41","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1128\/AAC.00122-11","article-title":"Antivirulence potential of TR-700 and clindamycin on clinical isolates of Staphylococcus aureus producing phenol-soluble modulins","volume":"55","author":"Yamaki","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B42","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1128\/AAC.00470-13","article-title":"Tigecycline induction of phenol-soluble modulins by invasive methicillin-resistant Staphylococcus aureus strains","volume":"57","author":"Yamaki","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B43","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1093\/jac\/dkt073","article-title":"Effects of subinhibitory concentrations of antibiotics on virulence factor expression by community-acquired methicillin-resistant Staphylococcus aureus","volume":"68","author":"Otto","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B44","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/jac\/dky087","article-title":"Unexpected synergistic and antagonistic antibiotic activity against Staphylococcus biofilms","volume":"73","author":"Dall","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B45","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrmicro1557","article-title":"Persister cells, dormancy and infectious disease","volume":"5","author":"Lewis","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B46","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrd1008","article-title":"Understanding biofilm resistance to antibacterial agents","volume":"2","author":"Davies","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B47","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.diagmicrobio.2017.07.001","article-title":"In vitro activities of tedizolid and comparator antimicrobial agents against clinical isolates of Staphylococcus aureus collected in 12 countries from 2014 to 2016","volume":"89","author":"Karlowsky","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B48","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1128\/AAC.01146-08","article-title":"Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: study of antibiotic combinations","volume":"53","author":"Nguyen","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019021507302860100_dky473-B49","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/infdis\/jiv319","article-title":"An essential role for coagulase in Staphylococcus aureus biofilm development reveals new therapeutic possibilities for device-related infections","volume":"212","author":"Zapotoczna","year":"2015","journal-title":"J Infect Dis"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/74\/3\/625\/27785372\/dky473.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T12:43:54Z","timestamp":1550234634000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/74\/3\/625\/5230874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,4]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,12,4]]},"published-print":{"date-parts":[[2019,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dky473","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,3]]},"published":{"date-parts":[[2018,12,4]]}}}